Twitter
Advertisement

Sun Pharma, SPARC shares down over 2% on rejected anti-epileptic drug application

The company had earlier received a final approval from USFDA in March 2015 for this product, and was evaluating several marketing partners for commercialisation, it added.

Latest News
article-main
Sun Pharma Logo
FacebookTwitterWhatsappLinkedin

Shares of Sun Pharma and Sun Pharma Advanced Research Company were trading below the red line on Monday, after the pharmaceutical company's anti epileptic drug application was rejected by the US health regulator. 

At 1059 am, Sun Pharmaceutical's share were trading down 3.02% or Rs 26.90 lower at Rs 864.40 from previous day's close on BSE. 

At 1101 am, the shares of Sun Pharma Advanced Research Company were down 2.60% or Rs 10.05 lower at Rs 375.85 from previous day's close on BSE. 

The US Food and Drug Administration (USFDA) has issued a Complete Response letter (CRL) to the company's new drug application (NDA) for Elepsia XR," Sun Pharma Advanced Research Company (SPARC) said in a statement.

The company had earlier received a final approval from USFDA in March 2015 for this product, and was evaluating several marketing partners for commercialisation, it added.

"However SPARC has now received a CRL from the USFDA rescinding its earlier approval, citing that the compliance status of the manufacturing facility was not acceptable on the date of approval," it said.

Elepsia XR is to be manufactured at Sun Pharmaceutical Industries s Halol facility. The Mumbai-based drug major is working with USFDA in resolving the current good manufacturing practice(cGMP) deviations at the facility and has taken several corrective measures.

Under new regulations, USFDA's Center for Drug Evaluation and Research (CDER) no longer issues "approvable" or "not approvable" letters when a drug application is not approved.

Instead, CDER issues a "complete response" letter at the end of the review period to let a drug company know of the agency s decision on the application.

Find your daily dose of news & explainers in your WhatsApp. Stay updated, Stay informed-  Follow DNA on WhatsApp.
Advertisement

Live tv

Advertisement
Advertisement